EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Synergistic Efficiency of a Novel Temperate Phage YF1204 and Amikacin Against Carbapenem-Resistant Pseudomonas aeruginosa and Its Biofilms

Yinfeng Yang iD, Noura M Bin Yahia, Yafei Pan, Zhaoxia Ran, Jing Yang, Yanhui Yang iD, Gang Li

Microorganisms · 27.02.2026 · 14 (3) · 549

DOI: 10.3390/microorganisms14030549 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Microorganisms, online erschienen am 27.02.2026. Verfasst von Yinfeng Yang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Center of Medical Laboratory, General Hospital of Ningxia Medical University, Ningxia Key Laboratory of Clinical and Pathogenic Microbiology, General…. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Open Project of Ningxia Key Laboratory of Clinical and Pathogenic Microbiology, Natural Science Foundation of Ningxia, Research Projects for Social Development of Ningxia Hui Autonomous Region.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Infections caused by carbapenem-resistant Pseudomonas aeruginosa (CRPA), especially chronic infections associated with biofilm formation, have become a major clinical challenge. Phage therapy has received much attention as an alternative strategy, but temperate phages have limited direct application due to their lysogenicity. The aim of this study was to explore the synergistic therapeutic effect of a novel temperate phage combined with antibiotics. A temperate Pseudomonas phage YF1204 was isolated from the patient’s bronchoalveolar lavage fluid and systematically characterized by whole-genome sequencing, transmission electron microscopy, and host range analysis. The synergistic antibacterial and anti-biofilm effects of phage with amikacin (AK) were evaluated by using the checkerboard test, a time-killing curve based on optical density (OD600) and crystal violet staining, and the cytocompatibility was analyzed by using the CCK-8 method. The results showed that phage YF1204 belonged to the Siphoviridae family and had typical temperate phage genome characteristics (containing integrase gene). It also showed lytic activity against 41.4% (87/210) of the clinical isolates, especially against carbapenem-resistant strains. When YF1204 was combined with AK, it reduced the minimum inhibitory concentration (MIC) of AK by 2- to 8-fold across all tested strains, respectively. Moreover, the inhibitory effect against CRPA was significantly enhanced (achieving suppression indexes about 80% ) and biofilm formation was inhibited with an inhibition ratio of 48.75%. Cell experiments showed that YF1204 had no significant toxicity to THP-1 cells. The combination of YF1204 and AK exhibited significant synergistic bactericidal and anti-biofilm activities, providing a novel therapeutic strategy with translational potential for CRPA-induced refractory infections.

Schlagwörter

Stichwörter der Autor:innen

Pseudomonas aeruginosaamikacincarbapenem resistancephage-antibiotic synergytemperate bacteriophage

Autor:innen und Institutionen

  • Center of Medical Laboratory, General Hospital of Ningxia Medical University, Ningxia Key Laboratory of Clinical and Pathogenic Microbiology, General Hospital of Ningxia Medical University, Yinchuan 750004, China.
  • Ningxia Key Laboratory of Infectious and Immunity, School of Basic Medical Sciences, Ningxia Medical University, Ningxia Key Laboratory of Clinical and Pathogenic Microbiology, General Hospital of Ningxia Medical Univer…

ORCID-Profile: Yinfeng Yang, Yanhui Yang

Förderung

  • Open Project of Ningxia Key Laboratory of Clinical and Pathogenic Microbiology
  • Natural Science Foundation of Ningxia
  • Research Projects for Social Development of Ningxia Hui Autonomous Region
  • 2024 Newly Recruited Master’s Talent Training Program of Ningxia Medical University General Hospital

Zitieren

APA

Yang, Y., Bin Yahia, N. M., Pan, Y., Ran, Z., Yang, J., Yang, Y., & Li, G. (2026). Synergistic Efficiency of a Novel Temperate Phage YF1204 and Amikacin Against Carbapenem-Resistant Pseudomonas aeruginosa and Its Biofilms. Microorganisms, 14(3), 549. https://doi.org/10.3390/microorganisms14030549

Vancouver

Yang Y, Bin Yahia NM, Pan Y, Ran Z, Yang J, Yang Y, et al. Synergistic Efficiency of a Novel Temperate Phage YF1204 and Amikacin Against Carbapenem-Resistant Pseudomonas aeruginosa and Its Biofilms. Microorganisms. 2026;14(3):549. doi:10.3390/microorganisms14030549

BibTeX
@article{Yang2026,
  author = {Yang, Yinfeng and Bin Yahia, Noura M and Pan, Yafei and Ran, Zhaoxia and Yang, Jing and Yang, Yanhui and Li, Gang},
  title = {Synergistic Efficiency of a Novel Temperate Phage YF1204 and Amikacin Against Carbapenem-Resistant Pseudomonas aeruginosa and Its Biofilms},
  journal = {Microorganisms},
  year = {2026},
  volume = {14},
  number = {3},
  pages = {549},
  doi = {10.3390/microorganisms14030549}
}
Kostenlos starten →